Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Kristen M. Marks"'
Autor:
Shashi N. Kapadia, Yesenia Aponte-Melendez, Alicia Rodriguez, Melinda Pai, Benjamin J. Eckhardt, Kristen M. Marks, Chunki Fong, Pedro Mateu-Gelabert
Publikováno v:
Harm Reduction Journal, Vol 20, Iss 1, Pp 1-10 (2023)
Abstract Background Hepatitis C virus (HCV) treatment can effectively cure HCV among people who inject drugs (PWID). Perspectives of PWID treated in innovative models can reveal program features that address barriers to treatment, and guide implement
Externí odkaz:
https://doaj.org/article/b8a85e9c1a834d3880b26264277a9a56
Autor:
Shashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, Chunki Fong, Pedro Mateu-Gelabert, Kristen M Marks, Yesenia Aponte-Melendez, Bruce R Schackman
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 5, Iss , Pp 100109- (2022)
Background: Co-located hepatitis C treatment at syringe service programs (SSP) is an emerging model of care for people who inject drugs (PWID). Implementation of these models can be informed by understanding the program costs. Methods: We conducted a
Externí odkaz:
https://doaj.org/article/93f8b234f5194f9caf495ba509c92064
Autor:
Hui Li, Kristen M Marks, Andrew H Talal, Wouter O van Seggelen, Bisher Akil, Asa Radix, Shirish Huprikar, Andrea D Branch, Shuyi Wang, George M Shaw, Daniel S Fierer
Publikováno v:
PLoS ONE, Vol 15, Iss 7, p e0235237 (2020)
The epidemic of hepatitis C virus (HCV) infection among HIV-infected men who have sex with men (MSM) is in its second decade, but the routes of transmission remain poorly understood. We hypothesized that by pairing single genome sequencing (SGS), to
Externí odkaz:
https://doaj.org/article/73ef32d2cb024848b1998838fcb71db4
Autor:
Benjamin Eckhardt, Pedro Mateu-Gelabert, Yesenia Aponte-Melendez, Chunki Fong, Shashi Kapadia, Melinda Smith, Brian R. Edlin, Kristen M. Marks
Publikováno v:
JAMA Intern Med
IMPORTANCE: To achieve hepatitis C elimination, treatment programs need to engage, treat, and cure people who inject drugs. OBJECTIVE: To compare a low-threshold, nonstigmatizing hepatitis C treatment program that was colocated at a syringe service p
Publikováno v:
Med Care
Background Hepatitis C virus (HCV) remains under-treated in the United States and treatment by nonspecialist providers can expand access. We compare HCV treatment provision and treatment completion between nonspecialist and specialist providers. Meth
Autor:
Samit Desai, Kristen M. Marks, Suzanne J Rose, Sigal Yawetz, Pritha Sen, Shawn Mazur, Jose F. Suarez, Diana M. Brainard, Yang Zhao, Matthew D Sims, Moupali Das, Magdalena E. Sobieszczyk, Cecilia Big, Ilona T. Goldfarb, Brian G. Blackburn, Ai-ris Y. Collier, Christoph C Carter, Susanna K Tan, Olga A. Kovalenko, Geeta K. Swamy, William R. Short, Jason Hindman, Adam DeZure, Tom Hahambis, Richard M. Burwick, Gregory Morlin, Adi Hirshberg, Anu Osinusi, Rebecca Zash, Laura Telep, Tilly A. Varughese, Anand P Chokkalingam, Mariam Naqvi, E Milunka Kojic, Kathryn E. Stephenson, Jeanne S. Sheffield, Oriol Manuel
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
Clinical infectious diseases, vol. 73, no. 11, pp. e3996-e4004
Clinical Infectious Diseases
Clinical infectious diseases, vol. 73, no. 11, pp. e3996-e4004
Background Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in pregnant women are limited. We describe outcomes in the first 86 pregnant women with severe COVID-19 who were treated with remdesivir. Methods
Autor:
Benjamin Eckhardt, Shashi N Kapadia, Pedro Mateu-Gelabert, Melinda Pai, Chunki Fong, Yesenia Aponte-Melendez, Kristen M Marks
Publikováno v:
Open forum infectious diseases. 9(7)
Background Young people who inject drugs (PWID) have high hepatitis C virus (HCV) incidence and low treatment initiation rates. Novel, simplified care models need to be developed to engage, treat, and cure hard-to-reach patient populations, such as y
Autor:
Chunki Fong, Kristen M. Marks, Yesenia Aponte-Melendez, Shashi N Kapadia, Benjamin Eckhardt, Pedro Mateu-Gelabert
Publikováno v:
Harm Reduction Journal
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-12 (2021)
Background While people who inject drugs (PWID) are vulnerable to the adverse outcomes of events like COVID-19, little is known regarding the impact of the current pandemic on PWID. We examine how COVID-19 has affected PWID in New York City across fo
Publikováno v:
Journal of Medical Virology
The antiviral remdesivir has been shown to decrease the length of hospital stay in coronavirus disease 2019 (COVID‐19) patients requiring supplemental oxygen. However many patients decompensate despite being treated with remdesivir. To identify pot
Autor:
Kristen M. Marks, Mirella Salvatore, Megan Savage, Grace A. Maldarelli, Corrina Oxford-Horrey, Shawn Mazur
Publikováno v:
Open Forum Infectious Diseases
We report a case of COVID-19 in third-trimester pregnancy, who required support in an intensive care unit and received remdesivir. After discharge, she had an uncomplicated vaginal delivery at term. COVID-19 in pregnancy may be managed without emerge